Published in Arch Toxicol Suppl on January 01, 1989
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med (1967) 2.09
Toxic hepatitis by clozapine treatment. Am J Psychiatry (1993) 1.83
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut (1992) 1.60
ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet (1982) 1.49
"Autoallergic" hepatitis. N Engl J Med (1970) 1.46
Non-organ-specific cytoplasmic antibodies detected by immunofluorescence. Int Arch Allergy Appl Immunol (1971) 1.46
Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol (1984) 1.46
Mitochondrial antibodies in primary biliary cirrhosis. 3. Characterization of the inner-membrane complement fixing antigen. Clin Exp Immunol (1969) 1.45
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. Mayo Clin Proc (1994) 1.44
Influence of special-effect contact lenses (Crazy Lenses) on visual function. CLAO J (1998) 1.44
Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology (1985) 1.43
Mitochondrial antibodies in primary biliary cirrhosis. IV. Significance of membrane structure for the complement-fixing antigen. Immunology (1969) 1.35
The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis. Semin Liver Dis (1981) 1.33
Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome. Clin Exp Immunol (1979) 1.27
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol (1982) 1.23
Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes. Br J Exp Pathol (1969) 1.22
Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol (1986) 1.22
Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet (1981) 1.21
Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol (1977) 1.20
Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives. Mol Pharmacol (2001) 1.18
Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin Exp Immunol (1982) 1.17
Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology (1991) 1.10
Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology (1998) 1.07
Isolation of immunoglobulin class switch variants from hybridoma lines secreting anti-idiotope antibodies by sequential sublining. J Immunol (1983) 1.07
Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer (1997) 1.06
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience (2010) 1.05
[Immunologic phenomena in liver diseases: significance of mitochondrial antibodies]. Klin Wochenschr (1969) 1.04
Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol Psychiatry (2012) 1.03
[Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis]. Dtsch Med Wochenschr (1973) 1.02
Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex. A clinical follow-up study. Clin Endocrinol (Oxf) (1982) 1.02
Serology of primary biliary cirrhosis. Springer Semin Immunopathol (1980) 1.02
Immunology of primary biliary cirrhosis. Baillieres Clin Gastroenterol (1987) 0.99
Caffeine analogs: structure-activity relationships at adenosine receptors. Pharmacology (1991) 0.99
Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology (1993) 0.98
Evidence for the expression of four myelin basic protein variants in the developing human spinal cord through cDNA cloning. J Neurosci Res (1987) 0.97
Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD. Clin Exp Immunol (1998) 0.97
Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism. Osteoporos Int (2009) 0.96
Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci (2001) 0.96
Clinical and prognostic relevance of different mitochondrial antibody profiles in primary biliary cirrhosis (PBC). Mol Aspects Med (1985) 0.95
TRACP 5b and CTX as osteological markers of delayed fracture healing. Injury (2010) 0.95
Studies on the metabolism of aristolochic acids I and II. Xenobiotica (1987) 0.95
Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9. Klin Wochenschr (1986) 0.95
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists. J Med Chem (2000) 0.94
Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis. Hepatology (1986) 0.94
[Chronic active (aggressive) hepatitis. Differential diagnosis of lupoid (ANA-positive) and cholestatic (AMA-positive) hepatitis]. Dtsch Med Wochenschr (1976) 0.94
Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance. Scand J Clin Lab Invest Suppl (1997) 0.94
Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi. Clin Lab (2006) 0.93
Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology (2012) 0.93
Separation of lipoxins and leukotrienes from human granulocytes by high-performance liquid chromatography with a Radial-Pak cartridge after extraction with an octadecyl reversed-phase column. J Chromatogr (1989) 0.92
[Wegener's granulomatosis: otologic and clinico-immunologic aspects]. Laryngorhinootologie (1992) 0.92
Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol (1988) 0.92
[Heterogenicity of mitochondrial antibodies (author's transl)]. Dtsch Med Wochenschr (1975) 0.92
Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol (1993) 0.91
A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases. Rheumatol Int (2000) 0.90
Demonstration of "naturally occurring mitochondrial antibodies" in family members of patients with primary biliary cirrhosis. Hepatology (1990) 0.90
Epidemiology of primary biliary cirrhosis. Liver (1984) 0.90
Autoantibodies and serum inhibition factors (sif) in patients with myocarditis. Klin Wochenschr (1980) 0.90
Bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp. J Nat Prod (1998) 0.90
Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation. Hepatology (1987) 0.89
[The 3 isomeric morpholine-Mannich-bases of paeonol]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.89
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet (2006) 0.89
Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase. Clin Exp Immunol (1990) 0.89
The impact of adenosine and A(2B) receptors on glucose homoeostasis. J Pharm Pharmacol (2006) 0.88
[Progressive inner ear diseases--sequelae of a secondary autoimmune process? Significance of antibodies to endoplasmic reticulum]. HNO (1987) 0.88
Isolation and characterization of a cDNA coding for a novel human 17.3K myelin basic protein (MBP) variant. J Neurosci Res (1986) 0.87
Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet (1981) 0.87
Natural course of primary biliary cirrhosis. I. A morphological, clinical and serological analysis of 103 cases. Liver (1982) 0.87
Methylxanthines block antigen-induced responses in RBL-2H3 cells independently of adenosine receptors or cyclic AMP: evidence for inhibition of antigen binding to IgE. J Pharmacol Exp Ther (1991) 0.87
Expression of myelin basic protein genes in several dysmyelinating mouse mutants during early postnatal brain development. J Neurochem (1985) 0.87
High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases. Ann Otol Rhinol Laryngol (1989) 0.87
Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. Eur J Neurosci (2000) 0.87
Immunological parameters in patients with congestive cardiomyopathy. Basic Res Cardiol (1980) 0.86
Idiotope regulation by isotype switch variants of two monoclonal antiidiotope antibodies. J Exp Med (1984) 0.86
The lymphocyte transformation test--a debated method for the evaluation of drug allergic hepatic injury. J Hepatol (1995) 0.86
Increase in soluble CD95L during subacute phases after human spinal cord injury: a potential therapeutic target. Spinal Cord (2012) 0.86
Demonstration of mitochondrial antibodies in sera from patients with chronic liver diseases reacting with two different types of complement-fixing antigens. Minerva Gastroenterol (1977) 0.85
The specificity of the lymphocyte transformation test in a patient with hypersensitivity reactions to pyrazolone compounds. A 10-week follow-up study before and after rechallenge. Eur J Clin Pharmacol (1988) 0.85
Chicken beta B1 crystallin: gene sequence and evidence for functional conservation of promoter activity between chicken and mouse. Biochim Biophys Acta (1995) 0.85
Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners. Environ Health Perspect (1998) 0.85
Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition. Kidney Blood Press Res (2004) 0.85
Demonstration of sensitized lymphocytes to trimethoprim/sulfamethoxazole and ofloxacin in a patient with cholestatic hepatitis. J Hepatol (1992) 0.85
The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis. J Hepatol (1988) 0.85
Anti-mitochondrial antibodies (anti-M7) in heart diseases recognize epitopes on bacterial and mammalian sarcosine dehydrogenase. Clin Exp Immunol (1990) 0.85
Ocular symptoms in association with antiphospholipid antibodies. Graefes Arch Clin Exp Ophthalmol (1998) 0.84
Convergent evolution of crystallin gene regulation in squid and chicken: the AP-1/ARE connection. J Mol Evol (1994) 0.84
Glutathione S-transferase as a major autoantigen in anti-SLA-positive autoimmune hepatitis. Gastroenterology (1999) 0.84
Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation. J Hepatol (1994) 0.84
Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans. Radiology (1990) 0.84
Determination of picogram amounts of lipoxin A4 and lipoxin B4 by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1988) 0.84
CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies. Br J Haematol (1996) 0.84
Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis. Clin Exp Immunol (1984) 0.84
Over-expression of the 18 kD and 21/23 kD fibroblast growth factor-2 isoforms in PC12 cells and Schwann cells results in altered cell morphology and growth. Brain Res Mol Brain Res (1998) 0.84
[Lung edema after administration of hydrochlorothiazide. A rare and life-threatening side effect]. Dtsch Med Wochenschr (1983) 0.84
Laminitis-like changes in the claws of feedlot cattle. Can Vet J (1990) 0.84